After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Johnson & Johnson is listed on the NYSE in the Healthcare sector while operating in the Drug Manufacturers – General industry. The current market capitalization of Johnson & Johnson is $390.76B. A total of 12.25 million shares were traded on the day, compared to an average of 8.67M shares.
In the most recent transaction, Schmid Timothy sold 403 shares of JNJ for 156.15 per share on Feb 18 ’25. After the transaction, the EVP, WW Chair, MedTech now owns 15,098 company shares. In a previous transaction on Feb 07 ’25, Wolk Joseph J sold 13,015 shares at 153.89 per share. JNJ shares that Exec VP, CFO owns now total 0.
Among the insiders who bought shares, Wolk Joseph J acquired of 13,015 shares on Feb 07 ’25 at a per-share price of $153.89. In another insider transaction, WEINBERGER MARK A bought 1,000 shares at $147.22 per share on Dec 12 ’24. Company shares held by the Director now total 1,000.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Johnson & Johnson pays an annual dividend of $4.96, resulting in a dividend yield of 3.06%, and it has a price to earnings (P/E) ratio of 28.00. JNJ’s most recent ex-dividend date was 3.43% when it declared a $1.24 quarterly dividend that was paid in cash on 2/18/2025. Previously, the company paid the dividend on 11/26/2024 with an ex-dividend date of 3.07%. The JNJ stock dividend was $1.24 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, JNJ has a high of $168.85 and a low of $140.68.
As of this writing, JNJ has an earnings estimate of $2.64 per share for the current quarter. EPS was calculated based on a consensus of 15.0 estimates, with a high estimate of $2.88 per share and a lower estimate of $2.51.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. JNJ’s latest balance sheet shows that the firm has $31.61B in Cash & Short Term Investments as of fiscal 2021. There were $33.75B in debt and $45.23B in liabilities at the time. Its Book Value Per Share was $29.70, while its Total Shareholder’s Equity was $74.02B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JNJ is Buy with a score of 3.82.
